Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Bank of India Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Bank of India | HDFC |
| NAV | ₹10.1100 | ₹23.6750 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 2.2 years | 3.1 years |
| Expense ratio | 1.4% | 1.1% |
| Stars | Not rated | ★★★★★ |
| Growth Score | — | 94.70 |
Returns
| Bank of India Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | +5.42% | +12.97% |
| 3 months | +1.00% | +7.13% |
| 6 months | +9.30% | +17.84% |
| YTD | +10.73% | +33.73% |
| 1 year | +7.10% | +32.20% |
| 3 years (CAGR) | — | +30.70% |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | +0.40% | +31.83% |
Risk
| Bank of India Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | — | 15.8% |
| Downside volatility | — | 8.5% |
| Sharpe | — | 1.53 |
| Sortino | — | 2.86 |
| Calmar | — | 2.06 |
| Return / risk | — | 1.95 |
| Deepest fall | −25.21% | −14.91% |
| Days to recover | — | 126 |
| Below its high | −3.44% | +0.00% |
Against benchmark
| Bank of India Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | — | +7.32% |
| Beta | — | 0.97 |
| R² | — | 85.0% |
| Up capture | — | 108.5% |
| Down capture | — | 71.5% |
| Tracking error | — | 6.1% |
| Information ratio | — | 1.13 |
| Treynor | — | 0.24 |
Consistency
| Bank of India Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +12.64% | +67.01% |
| Middle 1-year | +1.89% | +23.25% |
| Worst 1-year | −13.31% | +1.71% |
| 1-year periods with a loss | 41.7% | 0.0% |
| Middle 3-year | — | +30.22% |
| Positive months | — | 72.2% |
| Best day | +4.23% | +3.18% |
| Worst day | −3.87% | −3.61% |
| Worst 5% day | −1.77% | −1.51% |
| Positive days | 49.7% | 58.3% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Bank of India Business Cycle Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | — | +27.71% |
| 1-year XIRR | +15.54% | +41.37% |
Holdings overlap i
Overlap compares the shares two funds hold, so it needs at least two of these funds with shares in a loaded monthly filing.
- Bank of India Business Cycle Fund: no monthly portfolio filing from Bank of India is loaded yet, so it is left out here.
- HDFC Pharma and Healthcare Fund: no monthly portfolio filing from HDFC is loaded yet, so it is left out here.